United States · Who invested in Rheostat Therapeutics?
Rheostat Therapeutics's investors include Alexandria Real Estate Equities, Mayo Clinic, SV Health Investors, Dementia Discovery Fund and AbbVie Ventures/ Amgen, and 1 more on record.
United States · Series A startup
Who invested in Rheostat Therapeutics
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $23MNov 2018
- Investors
- 6
The rounds
- Nov 2018Series A$23M
Alexandria Real Estate Equities
Mayo Clinic- SV Health Investors
Dementia Discovery Fund- AbbVie Ventures/ Amgen
- MRLV
Reported by FinSMEs
Everyone who backed them
SV Health InvestorsVC firm1round
AbbVie Ventures/ Amgenno record of our own yet1round
MRLVno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rheostat Therapeutics
How much has Rheostat Therapeutics raised?
Rheostat Therapeutics has raised $23M across 1 round since 2018.
When did Rheostat Therapeutics last raise?
Rheostat Therapeutics's most recent round was a Series A of $23M in Nov 2018.
What was Rheostat Therapeutics's biggest round?
Its most recent round, $23M in Nov 2018, is also its largest on record.
Who backed Rheostat Therapeutics first?
Rheostat Therapeutics's first round on record, in Nov 2018, was backed by Alexandria Real Estate Equities, Mayo Clinic and SV Health Investors and 3 others.
What stage is Rheostat Therapeutics at?
Rheostat Therapeutics's latest named round is a Series A, in Nov 2018.
Where is Rheostat Therapeutics based?
Rheostat Therapeutics is based in the United States.
Companies like Rheostat Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.